Gomez-Navarro J - Search Results

1

Using a tropism-modified adenoviral vector to circumvent inhibitory factors in ascites fluid.

Blackwell JL, Li H, Gomez-Navarro J, Dmitriev I, Krasnykh V, Richter CA, Shaw DR, Alvarez RD, Curiel DT, Strong TV. Blackwell JL, et al. Hum Gene Ther. 2000 Aug 10;11(12):1657-69. doi: 10.1089/10430340050111313. Hum Gene Ther. 2000. PMID: 10954900

2

Targeted adenoviral vectors for cancer gene therapy.

Bilbao G, Gómez-Navarro J, Curiel DT. Bilbao G, et al. Adv Exp Med Biol. 1998;451:365-74. doi: 10.1007/978-1-4615-5357-1_57. Adv Exp Med Biol. 1998. PMID: 10026898 Review.

3

An advanced generation of adenoviral vectors selectively enhances gene transfer for ovarian cancer gene therapy approaches.

Vanderkwaak TJ, Wang M, Gómez-Navarro J, Rancourt C, Dmitriev I, Krasnykh V, Barnes M, Siegal GP, Alvarez R, Curiel DT. Vanderkwaak TJ, et al. Gynecol Oncol. 1999 Aug;74(2):227-34. doi: 10.1006/gyno.1999.5432. Gynecol Oncol. 1999. PMID: 10419736

4

Pro-apoptotic treatment with an adenovirus encoding Bax enhances the effect of chemotherapy in ovarian cancer.

Xiang J, Gómez-Navarro J, Arafat W, Liu B, Barker SD, Alvarez RD, Siegal GP, Curiel DT. Xiang J, et al. J Gene Med. 2000 Mar-Apr;2(2):97-106. doi: 10.1002/(SICI)1521-2254(200003/04)2:2<97::AID-JGM99>3.0.CO;2-S. J Gene Med. 2000. PMID: 10809143

5

An adenovirus encoding proapoptotic Bax induces apoptosis and enhances the radiation effect in human ovarian cancer.

Arafat WO, Gómez-Navarro J, Xiang J, Barnes MN, Mahasreshti P, Alvarez RD, Siegal GP, Badib AO, Buchsbaum D, Curiel DT, Stackhouse MA. Arafat WO, et al. Mol Ther. 2000 Jun;1(6):545-54. doi: 10.1006/mthe.2000.0071. Mol Ther. 2000. PMID: 10933979 Free article.

6

Antineoplastic effect of anti-erbB-2 intrabody is not correlated with scFv affinity for its target.

Arafat W, Gómez-Navarro J, Xiang J, Siegal GP, Alvarez RD, Curiel DT. Arafat W, et al. Cancer Gene Ther. 2000 Sep;7(9):1250-6. doi: 10.1038/sj.cgt.7700228. Cancer Gene Ther. 2000. PMID: 11023197

7

Adenoviral-mediated suicide gene therapy for ovarian cancer.

Alvarez RD, Gomez-Navarro J, Wang M, Barnes MN, Strong TV, Arani RB, Arafat W, Hughes JV, Siegal GP, Curiel DT. Alvarez RD, et al. Mol Ther. 2000 Nov;2(5):524-30. doi: 10.1006/mthe.2000.0194. Mol Ther. 2000. PMID: 11082326 Free article. Clinical Trial.

8

An adenovirus with enhanced infectivity mediates molecular chemotherapy of ovarian cancer cells and allows imaging of gene expression.

Hemminki A, Belousova N, Zinn KR, Liu B, Wang M, Chaudhuri TR, Rogers BE, Buchsbaum DJ, Siegal GP, Barnes MN, Gomez-Navarro J, Curiel DT, Alvarez RD. Hemminki A, et al. Mol Ther. 2001 Sep;4(3):223-31. doi: 10.1006/mthe.2001.0446. Mol Ther. 2001. PMID: 11545613 Free article.

9

Effective single chain antibody (scFv) concentrations in vivo via adenoviral vector mediated expression of secretory scFv.

Arafat WO, Gómez-Navarro J, Buchsbaum DJ, Xiang J, Wang M, Casado E, Barker SD, Mahasreshti PJ, Haisma HJ, Barnes MN, Siegal GP, Alvarez RD, Hemminki A, Nettelbeck DM, Curiel DT. Arafat WO, et al. Gene Ther. 2002 Feb;9(4):256-62. doi: 10.1038/sj.gt.3301639. Gene Ther. 2002. PMID: 11896464

10

Conditionally replicative adenoviral vectors for cancer gene therapy.

Gómez-Navarro J, Curiel DT. Gómez-Navarro J, et al. Lancet Oncol. 2000 Nov;1:148-58. doi: 10.1016/s1470-2045(00)00030-9. Lancet Oncol. 2000. PMID: 11905653 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

64 results

Search Page

Filters